CSIMarket
 


Fulcrum Therapeutics Inc   (FULC)
Other Ticker:  
 
 

FULC's Operating Income Growth by Quarter and Year

Fulcrum Therapeutics Inc 's Operating Income results by quarter and year




FULC Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 30.50 0.00 0.00
III Quarter September - -17.01 0.00 0.00
II Quarter June - -13.49 0.00 0.00
I Quarter March -18.80 0.00 0.00 0.00
FY   -18.80 -0.00 - -



FULC Operating Income first quarter 2020 Y/Y Growth Comment
Fulcrum Therapeutics Inc in the first quarter recorded Operating Loss of $ -18.80 millions.

According to the results reported in the first quarter, Fulcrum Therapeutics Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Fulcrum Therapeutics Inc ' s Operating Income no change of % ranks overall at the positon no. in the first quarter.

Explain Operating Income growth


FULC Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Fulcrum Therapeutics Inc 's first quarter 2020 Operating Income $ -18.80 millions FULC's Income Statement
Fulcrum Therapeutics Inc 's first quarter 2019 Operating Income $ 0.00 millions Quarterly FULC's Income Statement
New: More FULC's historic Operating Income Growth >>


FULC Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Fulcrum Therapeutics Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FULC's I. Quarter Q/Q Operating Income Comment
Current results of -18.80 millions by Fulcrum Therapeutics Inc appear even less good if you take a look at 30.50 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry Fulcrum Therapeutics Inc achieved highest sequential Operating Income growth. While Fulcrum Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FULC's I. Quarter Q/Q Operating Income Comment
Recent results of -18.80 millions by Fulcrum Therapeutics Inc appear even more unfavourable compare to the 30.50 millions Operating Loss a quarter before.

Within Major Pharmaceutical Preparations industry Fulcrum Therapeutics Inc achieved highest sequential Operating Income growth. While Fulcrum Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Fulcrum Therapeutics Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
Cumulative Operating Income 12 Months Ending $ -18.80 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Fulcrum Therapeutics Inc ' has realized cumulative trailing twelve months Operating Loss of $ -19 millions in the Mar 31 2020 period.
The business is getting worse as the cumulative Operating Loss is becoming larger from $ 0 millions in the twelve months ending a quarter before and $ 30.5 millions for the twelve months ending in the quarter a year ago.

Fulcrum Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Fulcrum Therapeutics Inc ' has realized cumulative trailing twelve months Operating Loss of $ -19 millions in the Mar 31 2020 period.
The situation is worsening as the cumulative Operating Loss is becoming larger from $ 0 millions in the twelve months ending a quarter before and $ 30.5 millions for the twelve months ending in the quarter .

Fulcrum Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
FULC's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for FULC's Competitors
Operating Income Growth for Fulcrum Therapeutics Inc 's Suppliers
Operating Income Growth for FULC's Customers

You may also want to know
FULC's Annual Growth Rates FULC's Profitability Ratios FULC's Asset Turnover Ratio FULC's Dividend Growth
FULC's Roe FULC's Valuation Ratios FULC's Financial Strength Ratios FULC's Dividend Payout Ratio
FULC's Roa FULC's Inventory Turnover Ratio FULC's Growth Rates FULC's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2020
Amedisys Inc -1.02 %$ -1.024 millions
Lemaitre Vascular Inc -1.85 %$ -1.849 millions
Hca Healthcare Inc -2.78 %$ -2.784 millions
Mettler Toledo International Inc -3.03 %$ -3.027 millions
Genesis Healthcare Inc -4.96 %$ -4.963 millions
Phibro Animal Health Corp -5.53 %$ -5.534 millions
Utah Medical Products Inc -5.80 %$ -5.803 millions
Pfizer Inc -7.00 %$ -7.000 millions
Illumina Inc -7.35 %$ -7.353 millions
Iqvia Holdings Inc -8.10 %$ -8.095 millions
Brookdale Senior Living Inc -10.57 %$ -10.570 millions
Abiomed Inc -11.22 %$ -11.219 millions
Tenet Healthcare Corp -11.86 %$ -11.860 millions
Bausch Health Companies Inc -13.59 %$ -13.589 millions
Icu Medical Inc -14.21 %$ -14.207 millions
Integra Lifesciences Holdings Corp -16.11 %$ -16.111 millions
U s Neurosurgical Holdings Inc -18.12 %$ -18.121 millions
Orgenesis Inc -18.61 %$ -18.615 millions
Pra Health Sciences Inc -19.74 %$ -19.744 millions
Integrated Biopharma Inc -22.39 %$ -22.393 millions
Procyon Corp -23.41 %$ -23.412 millions
Biolife Solutions Inc -24.64 %$ -24.644 millions
Immucell Corp -25.79 %$ -25.792 millions
Integrity Applications Inc -26.30 %$ -26.297 millions
Owens and Minor Inc -26.79 %$ -26.790 millions
Quest Diagnostics Inc -29.44 %$ -29.435 millions
Universal Health Services Inc -30.47 %$ -30.473 millions
Regional Health Properties Inc -34.86 %$ -34.860 millions
Community Health Systems Inc -41.80 %$ -41.799 millions
Synergy Chc Corp -44.87 %$ -44.869 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CCCL's Profile

Stock Price

CCCL's Financials

Business Description

Fundamentals

Charts & Quotes

CCCL's News

Suppliers

CCCL's Competitors

Customers & Markets

Economic Indicators

CCCL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071